Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Arcadia Biosciences, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +1 vs. Q1 2026
- Shares held
- 212.5K
- −137.9K (−39.4%) vs. Q1 2026
- Total value
- $146.5K
- −$337.0K (−69.7%) vs. Q1 2026
- New holders
- 8
- 0 more added
- Sold out
- 7
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RKDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $146.5K |
| Q1 2026 | 17 | $483.5K |
| Q4 2025 | 13 | $77.4K |
| Q3 2025 | 16 | $227.2K |
| Q2 2025 | 14 | $259.1K |
| Q1 2025 | 14 | $222.1K |
| Q4 2024 | 13 | $464.9K |
| Q3 2024 | 13 | $149.0K |
| Q2 2024 | 11 | $90.4K |
| Q1 2024 | 14 | $178.3K |
| Q4 2023 | 15 | $430.7K |
| Q3 2023 | 12 | $158.6K |
| Q2 2023 | 13 | $538.0K |
| Q1 2023 | 15 | $1.21M |
| Q4 2022 | 29 | $639.5K |
| Q3 2022 | 24 | $1.73M |
| Q2 2022 | 22 | $1.71M |
| Q1 2022 | 25 | $2.69M |
| Q4 2021 | 27 | $2.43M |
| Q3 2021 | 21 | $6.54M |
| Q2 2021 | 27 | $7.40M |
| Q1 2021 | 23 | $3.17M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Arcadia Biosciences, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Southern Michigan Bank & Trust | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | +1 | New |
| Group One Trading, L.P. | 18 | $12 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 35 | $24 | 0.00% | −772−95.7% | Reduced |
| TD Waterhouse Canada Inc. | 70 | $50 | 0.00% | +70 | New |
| SBI Securities Co., Ltd. | 120 | $81 | 0.00% | 00.0% | Unchanged |
| Bullock Wealth Management Group | 1,000 | $749 | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 9,644 | $6.55K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,245 | $6.96K | 0.00% | +10,245 | New |
| State Street Corp | 12,146 | $8.25K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 15,475 | $10.5K | 0.00% | +15,475 | New |
| Geode Capital Management, LLC | 16,135 | $11.0K | 0.00% | −15,608−49.2% | Reduced |
| StoneX Group Inc. | 13,682 | $11.3K | 0.00% | +13,682 | New |
| Virtu Financial LLC | 21,786 | $15.0K | 0.00% | +21,786 | New |
| Citadel Advisors LLC | 23,738 | $16.1K | 0.00% | +23,738 | New |
| HRT Financial LP | 88,386 | $60.0K | 0.00% | +88,386 | New |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −159,390−100.0% | Sold out |
| Sabby Management, LLC | 0 | $0 | 0.00% | −114,554−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,614−100.0% | Sold out |
| Vanguard Fiduciary Trust Co | 0 | $0 | 0.00% | −4,394−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,940−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |